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A 52 year old male with a history of hypertension and tobacco abuse 
presented with severe abdominal pain, back pain, constipation and 
fever for the past four days. CT scan showed an occlusive thrombus 
of the superior mesenteric vein and its tributaries, thrombus of 
the portal vein, mesenteric edema, and an infarct of the left lobe 
of the liver. Erythrocytosis and leukocytosis were noted with a 
Hemoglobin of 19 g/dL, Hematocrit of 54%, and White Blood Cell 
Count of 20thou/cmm. The multiple extensive thrombi caused 
decreased intestinal blood flow leading to a partial small bowel 
obstruction, lactic acidosis and bowel ischemia further complicating 
the patient's clinical status. Initial workup of the erythrocytosis was 
unrevealing with a normal erythropoietin level of 18mU/mL and a 
negative JAK2 mutation. The patient later disclosed that he was 
using exogenous testosterone in the form of a gel for the last two 
years. It was prescribed to him for nonspecific symptoms including 
fatigue and decreased strength. Exogenous testosterone use was 
determined to be the etiology of his clinical presentation. Therapeutic 
phlebotomy was required to normalize hemoglobin and hematocrit 
levels. Thrombi treatment was completed with heparin infusion 
and rivaroxaban was initiated for a total of twelve months. The 
partial small bowel obstruction and bowel ischemia were treated 
conservatively and resolved with initiation of anti-coagulation. Most 
importantly, he was advised to cease testosterone gel use.
Background
•  Testosterone replacement therapy is used to treat male 
hypogonadism to improve muscle strength, bone health and 
sexual function. 
•  These benefits must be weighed against the potential adverse 
effects of testosterone use.
•  Exogenous testosterone use has increased more than seven fold in the 
last decade. Millions worldwide use testosterone for its beneficial effects 
with minimal knowledge of its potential serious complications. 
•  Erythrocytosis is a side effect of testosterone and is directly related to the 
increased risk of venous thromboembolism.
•  While the relationship between erythrocytosis and thromboembolic 
disease has been established, the use of testosterone itself may impart an 
increased risk of thromboembolism. 
•  Most cases of thromboembolism are associated with high doses of 
intravenous or oral testosterone use. This case is a rare presentation of 
testosterone gel leading to multiple large mesenteric and portal venous 
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Figure 1: Pathogenesis of testosterone causing erythrocyte proliferation 
